| Kirstin L Mikel, CRNA | |
|
1447 N Harrison St, Saginaw, MI 48602-4727 | |
| (231) 935-5770 | |
| Not Available |
| Full Name | Kirstin L Mikel |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 1447 N Harrison St, Saginaw, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275513616 | NPI | - | NPPES |
| 430B810310 | Other | MI | BCBS TSC |
| P00270473 | Other | MI | MEDICARE RR TSC |
| 46901017 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | KM220975 (Michigan) | Primary |
| Entity Name | American Anesthesiology Of Michigan Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487609475 PECOS PAC ID: 5294648804 Enrollment ID: O20031110000617 |
News Archive
Europe's most promising oncology biotechs and other key stakeholders will gather in Oslo, Norway, September 15-17 for the 2nd European Cancer Cluster Meeting (ECCP 2010). Co-hosted by the Oslo Cancer Cluster and the Cancer-Bio-Santé Cluster from Toulouse, the two-day meeting is a unique partnering opportunity for oncology biotech companies, business development and licensing executives from the pharmaceutical industry and investors, as well as innovative researchers and clinicians.
People who have had their appendix removed may be at an increased risk for developing Parkinson's disease, according to new research.
Gilead Sciences, Inc. and MicroDose Therapeutx, Inc. today announced that the companies have entered into an exclusive worldwide license and collaboration agreement for the development and commercialization of MDT-637, MicroDose's inhalable small molecule antiviral fusion inhibitor for the treatment of respiratory syncytial virus (RSV).
Extendicare Real Estate Investment Trust ("Extendicare REIT") (TSX:EXE.UN) announced that a judge in Milwaukee County Circuit Court ruled that a class action lawsuit brought against Extendicare Health Services, Inc., Extendicare Homes, Inc. and other related entities (collectively "Extendicare"), wholly owned U.S. based subsidiaries of Extendicare REIT, was improper and ordered the case dismissed in its entirety.
Trophos and AFM-Telethon today announce that data from the pivotal clinical trial of Trophos' lead product candidate olesoxime in spinal muscular atrophy (SMA) will be presented during the 66th American Academy of Neurology annual meeting to be held in Philadelphia, PA, USA, from April 26 to May 3 2014.
› Verified 4 days ago
| Entity Name | Covenant Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972590412 PECOS PAC ID: 2769387778 Enrollment ID: O20031209000107 |
News Archive
Europe's most promising oncology biotechs and other key stakeholders will gather in Oslo, Norway, September 15-17 for the 2nd European Cancer Cluster Meeting (ECCP 2010). Co-hosted by the Oslo Cancer Cluster and the Cancer-Bio-Santé Cluster from Toulouse, the two-day meeting is a unique partnering opportunity for oncology biotech companies, business development and licensing executives from the pharmaceutical industry and investors, as well as innovative researchers and clinicians.
People who have had their appendix removed may be at an increased risk for developing Parkinson's disease, according to new research.
Gilead Sciences, Inc. and MicroDose Therapeutx, Inc. today announced that the companies have entered into an exclusive worldwide license and collaboration agreement for the development and commercialization of MDT-637, MicroDose's inhalable small molecule antiviral fusion inhibitor for the treatment of respiratory syncytial virus (RSV).
Extendicare Real Estate Investment Trust ("Extendicare REIT") (TSX:EXE.UN) announced that a judge in Milwaukee County Circuit Court ruled that a class action lawsuit brought against Extendicare Health Services, Inc., Extendicare Homes, Inc. and other related entities (collectively "Extendicare"), wholly owned U.S. based subsidiaries of Extendicare REIT, was improper and ordered the case dismissed in its entirety.
Trophos and AFM-Telethon today announce that data from the pivotal clinical trial of Trophos' lead product candidate olesoxime in spinal muscular atrophy (SMA) will be presented during the 66th American Academy of Neurology annual meeting to be held in Philadelphia, PA, USA, from April 26 to May 3 2014.
› Verified 4 days ago
| Entity Name | Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235160532 PECOS PAC ID: 8527976497 Enrollment ID: O20040122000907 |
News Archive
Europe's most promising oncology biotechs and other key stakeholders will gather in Oslo, Norway, September 15-17 for the 2nd European Cancer Cluster Meeting (ECCP 2010). Co-hosted by the Oslo Cancer Cluster and the Cancer-Bio-Santé Cluster from Toulouse, the two-day meeting is a unique partnering opportunity for oncology biotech companies, business development and licensing executives from the pharmaceutical industry and investors, as well as innovative researchers and clinicians.
People who have had their appendix removed may be at an increased risk for developing Parkinson's disease, according to new research.
Gilead Sciences, Inc. and MicroDose Therapeutx, Inc. today announced that the companies have entered into an exclusive worldwide license and collaboration agreement for the development and commercialization of MDT-637, MicroDose's inhalable small molecule antiviral fusion inhibitor for the treatment of respiratory syncytial virus (RSV).
Extendicare Real Estate Investment Trust ("Extendicare REIT") (TSX:EXE.UN) announced that a judge in Milwaukee County Circuit Court ruled that a class action lawsuit brought against Extendicare Health Services, Inc., Extendicare Homes, Inc. and other related entities (collectively "Extendicare"), wholly owned U.S. based subsidiaries of Extendicare REIT, was improper and ordered the case dismissed in its entirety.
Trophos and AFM-Telethon today announce that data from the pivotal clinical trial of Trophos' lead product candidate olesoxime in spinal muscular atrophy (SMA) will be presented during the 66th American Academy of Neurology annual meeting to be held in Philadelphia, PA, USA, from April 26 to May 3 2014.
› Verified 4 days ago
| Entity Name | Covenant Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225151897 PECOS PAC ID: 2769387778 Enrollment ID: O20040209001142 |
News Archive
Europe's most promising oncology biotechs and other key stakeholders will gather in Oslo, Norway, September 15-17 for the 2nd European Cancer Cluster Meeting (ECCP 2010). Co-hosted by the Oslo Cancer Cluster and the Cancer-Bio-Santé Cluster from Toulouse, the two-day meeting is a unique partnering opportunity for oncology biotech companies, business development and licensing executives from the pharmaceutical industry and investors, as well as innovative researchers and clinicians.
People who have had their appendix removed may be at an increased risk for developing Parkinson's disease, according to new research.
Gilead Sciences, Inc. and MicroDose Therapeutx, Inc. today announced that the companies have entered into an exclusive worldwide license and collaboration agreement for the development and commercialization of MDT-637, MicroDose's inhalable small molecule antiviral fusion inhibitor for the treatment of respiratory syncytial virus (RSV).
Extendicare Real Estate Investment Trust ("Extendicare REIT") (TSX:EXE.UN) announced that a judge in Milwaukee County Circuit Court ruled that a class action lawsuit brought against Extendicare Health Services, Inc., Extendicare Homes, Inc. and other related entities (collectively "Extendicare"), wholly owned U.S. based subsidiaries of Extendicare REIT, was improper and ordered the case dismissed in its entirety.
Trophos and AFM-Telethon today announce that data from the pivotal clinical trial of Trophos' lead product candidate olesoxime in spinal muscular atrophy (SMA) will be presented during the 66th American Academy of Neurology annual meeting to be held in Philadelphia, PA, USA, from April 26 to May 3 2014.
› Verified 4 days ago
| Entity Name | Ascension St. Mary's Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457306185 PECOS PAC ID: 6305737156 Enrollment ID: O20040322001854 |
News Archive
Europe's most promising oncology biotechs and other key stakeholders will gather in Oslo, Norway, September 15-17 for the 2nd European Cancer Cluster Meeting (ECCP 2010). Co-hosted by the Oslo Cancer Cluster and the Cancer-Bio-Santé Cluster from Toulouse, the two-day meeting is a unique partnering opportunity for oncology biotech companies, business development and licensing executives from the pharmaceutical industry and investors, as well as innovative researchers and clinicians.
People who have had their appendix removed may be at an increased risk for developing Parkinson's disease, according to new research.
Gilead Sciences, Inc. and MicroDose Therapeutx, Inc. today announced that the companies have entered into an exclusive worldwide license and collaboration agreement for the development and commercialization of MDT-637, MicroDose's inhalable small molecule antiviral fusion inhibitor for the treatment of respiratory syncytial virus (RSV).
Extendicare Real Estate Investment Trust ("Extendicare REIT") (TSX:EXE.UN) announced that a judge in Milwaukee County Circuit Court ruled that a class action lawsuit brought against Extendicare Health Services, Inc., Extendicare Homes, Inc. and other related entities (collectively "Extendicare"), wholly owned U.S. based subsidiaries of Extendicare REIT, was improper and ordered the case dismissed in its entirety.
Trophos and AFM-Telethon today announce that data from the pivotal clinical trial of Trophos' lead product candidate olesoxime in spinal muscular atrophy (SMA) will be presented during the 66th American Academy of Neurology annual meeting to be held in Philadelphia, PA, USA, from April 26 to May 3 2014.
› Verified 4 days ago
| Entity Name | Superior Anesthetists Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831144518 PECOS PAC ID: 5890784987 Enrollment ID: O20040512000785 |
News Archive
Europe's most promising oncology biotechs and other key stakeholders will gather in Oslo, Norway, September 15-17 for the 2nd European Cancer Cluster Meeting (ECCP 2010). Co-hosted by the Oslo Cancer Cluster and the Cancer-Bio-Santé Cluster from Toulouse, the two-day meeting is a unique partnering opportunity for oncology biotech companies, business development and licensing executives from the pharmaceutical industry and investors, as well as innovative researchers and clinicians.
People who have had their appendix removed may be at an increased risk for developing Parkinson's disease, according to new research.
Gilead Sciences, Inc. and MicroDose Therapeutx, Inc. today announced that the companies have entered into an exclusive worldwide license and collaboration agreement for the development and commercialization of MDT-637, MicroDose's inhalable small molecule antiviral fusion inhibitor for the treatment of respiratory syncytial virus (RSV).
Extendicare Real Estate Investment Trust ("Extendicare REIT") (TSX:EXE.UN) announced that a judge in Milwaukee County Circuit Court ruled that a class action lawsuit brought against Extendicare Health Services, Inc., Extendicare Homes, Inc. and other related entities (collectively "Extendicare"), wholly owned U.S. based subsidiaries of Extendicare REIT, was improper and ordered the case dismissed in its entirety.
Trophos and AFM-Telethon today announce that data from the pivotal clinical trial of Trophos' lead product candidate olesoxime in spinal muscular atrophy (SMA) will be presented during the 66th American Academy of Neurology annual meeting to be held in Philadelphia, PA, USA, from April 26 to May 3 2014.
› Verified 4 days ago
| Entity Name | Waterford Anesthesia, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376862474 PECOS PAC ID: 6901090489 Enrollment ID: O20101028000689 |
News Archive
Europe's most promising oncology biotechs and other key stakeholders will gather in Oslo, Norway, September 15-17 for the 2nd European Cancer Cluster Meeting (ECCP 2010). Co-hosted by the Oslo Cancer Cluster and the Cancer-Bio-Santé Cluster from Toulouse, the two-day meeting is a unique partnering opportunity for oncology biotech companies, business development and licensing executives from the pharmaceutical industry and investors, as well as innovative researchers and clinicians.
People who have had their appendix removed may be at an increased risk for developing Parkinson's disease, according to new research.
Gilead Sciences, Inc. and MicroDose Therapeutx, Inc. today announced that the companies have entered into an exclusive worldwide license and collaboration agreement for the development and commercialization of MDT-637, MicroDose's inhalable small molecule antiviral fusion inhibitor for the treatment of respiratory syncytial virus (RSV).
Extendicare Real Estate Investment Trust ("Extendicare REIT") (TSX:EXE.UN) announced that a judge in Milwaukee County Circuit Court ruled that a class action lawsuit brought against Extendicare Health Services, Inc., Extendicare Homes, Inc. and other related entities (collectively "Extendicare"), wholly owned U.S. based subsidiaries of Extendicare REIT, was improper and ordered the case dismissed in its entirety.
Trophos and AFM-Telethon today announce that data from the pivotal clinical trial of Trophos' lead product candidate olesoxime in spinal muscular atrophy (SMA) will be presented during the 66th American Academy of Neurology annual meeting to be held in Philadelphia, PA, USA, from April 26 to May 3 2014.
› Verified 4 days ago
| Entity Name | Resource Anesthesiology Associates Of Mi Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568755882 PECOS PAC ID: 4082883053 Enrollment ID: O20110808000715 |
News Archive
Europe's most promising oncology biotechs and other key stakeholders will gather in Oslo, Norway, September 15-17 for the 2nd European Cancer Cluster Meeting (ECCP 2010). Co-hosted by the Oslo Cancer Cluster and the Cancer-Bio-Santé Cluster from Toulouse, the two-day meeting is a unique partnering opportunity for oncology biotech companies, business development and licensing executives from the pharmaceutical industry and investors, as well as innovative researchers and clinicians.
People who have had their appendix removed may be at an increased risk for developing Parkinson's disease, according to new research.
Gilead Sciences, Inc. and MicroDose Therapeutx, Inc. today announced that the companies have entered into an exclusive worldwide license and collaboration agreement for the development and commercialization of MDT-637, MicroDose's inhalable small molecule antiviral fusion inhibitor for the treatment of respiratory syncytial virus (RSV).
Extendicare Real Estate Investment Trust ("Extendicare REIT") (TSX:EXE.UN) announced that a judge in Milwaukee County Circuit Court ruled that a class action lawsuit brought against Extendicare Health Services, Inc., Extendicare Homes, Inc. and other related entities (collectively "Extendicare"), wholly owned U.S. based subsidiaries of Extendicare REIT, was improper and ordered the case dismissed in its entirety.
Trophos and AFM-Telethon today announce that data from the pivotal clinical trial of Trophos' lead product candidate olesoxime in spinal muscular atrophy (SMA) will be presented during the 66th American Academy of Neurology annual meeting to be held in Philadelphia, PA, USA, from April 26 to May 3 2014.
› Verified 4 days ago
| Entity Name | Asa Staffing Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114378981 PECOS PAC ID: 3971898644 Enrollment ID: O20160818002713 |
News Archive
Europe's most promising oncology biotechs and other key stakeholders will gather in Oslo, Norway, September 15-17 for the 2nd European Cancer Cluster Meeting (ECCP 2010). Co-hosted by the Oslo Cancer Cluster and the Cancer-Bio-Santé Cluster from Toulouse, the two-day meeting is a unique partnering opportunity for oncology biotech companies, business development and licensing executives from the pharmaceutical industry and investors, as well as innovative researchers and clinicians.
People who have had their appendix removed may be at an increased risk for developing Parkinson's disease, according to new research.
Gilead Sciences, Inc. and MicroDose Therapeutx, Inc. today announced that the companies have entered into an exclusive worldwide license and collaboration agreement for the development and commercialization of MDT-637, MicroDose's inhalable small molecule antiviral fusion inhibitor for the treatment of respiratory syncytial virus (RSV).
Extendicare Real Estate Investment Trust ("Extendicare REIT") (TSX:EXE.UN) announced that a judge in Milwaukee County Circuit Court ruled that a class action lawsuit brought against Extendicare Health Services, Inc., Extendicare Homes, Inc. and other related entities (collectively "Extendicare"), wholly owned U.S. based subsidiaries of Extendicare REIT, was improper and ordered the case dismissed in its entirety.
Trophos and AFM-Telethon today announce that data from the pivotal clinical trial of Trophos' lead product candidate olesoxime in spinal muscular atrophy (SMA) will be presented during the 66th American Academy of Neurology annual meeting to be held in Philadelphia, PA, USA, from April 26 to May 3 2014.
› Verified 4 days ago
| Entity Name | Axon Anesthesia Consultants Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235643495 PECOS PAC ID: 7012276819 Enrollment ID: O20180124003392 |
News Archive
Europe's most promising oncology biotechs and other key stakeholders will gather in Oslo, Norway, September 15-17 for the 2nd European Cancer Cluster Meeting (ECCP 2010). Co-hosted by the Oslo Cancer Cluster and the Cancer-Bio-Santé Cluster from Toulouse, the two-day meeting is a unique partnering opportunity for oncology biotech companies, business development and licensing executives from the pharmaceutical industry and investors, as well as innovative researchers and clinicians.
People who have had their appendix removed may be at an increased risk for developing Parkinson's disease, according to new research.
Gilead Sciences, Inc. and MicroDose Therapeutx, Inc. today announced that the companies have entered into an exclusive worldwide license and collaboration agreement for the development and commercialization of MDT-637, MicroDose's inhalable small molecule antiviral fusion inhibitor for the treatment of respiratory syncytial virus (RSV).
Extendicare Real Estate Investment Trust ("Extendicare REIT") (TSX:EXE.UN) announced that a judge in Milwaukee County Circuit Court ruled that a class action lawsuit brought against Extendicare Health Services, Inc., Extendicare Homes, Inc. and other related entities (collectively "Extendicare"), wholly owned U.S. based subsidiaries of Extendicare REIT, was improper and ordered the case dismissed in its entirety.
Trophos and AFM-Telethon today announce that data from the pivotal clinical trial of Trophos' lead product candidate olesoxime in spinal muscular atrophy (SMA) will be presented during the 66th American Academy of Neurology annual meeting to be held in Philadelphia, PA, USA, from April 26 to May 3 2014.
› Verified 4 days ago
| Entity Name | Environ Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831438092 PECOS PAC ID: 3870717754 Enrollment ID: O20180227002190 |
News Archive
Europe's most promising oncology biotechs and other key stakeholders will gather in Oslo, Norway, September 15-17 for the 2nd European Cancer Cluster Meeting (ECCP 2010). Co-hosted by the Oslo Cancer Cluster and the Cancer-Bio-Santé Cluster from Toulouse, the two-day meeting is a unique partnering opportunity for oncology biotech companies, business development and licensing executives from the pharmaceutical industry and investors, as well as innovative researchers and clinicians.
People who have had their appendix removed may be at an increased risk for developing Parkinson's disease, according to new research.
Gilead Sciences, Inc. and MicroDose Therapeutx, Inc. today announced that the companies have entered into an exclusive worldwide license and collaboration agreement for the development and commercialization of MDT-637, MicroDose's inhalable small molecule antiviral fusion inhibitor for the treatment of respiratory syncytial virus (RSV).
Extendicare Real Estate Investment Trust ("Extendicare REIT") (TSX:EXE.UN) announced that a judge in Milwaukee County Circuit Court ruled that a class action lawsuit brought against Extendicare Health Services, Inc., Extendicare Homes, Inc. and other related entities (collectively "Extendicare"), wholly owned U.S. based subsidiaries of Extendicare REIT, was improper and ordered the case dismissed in its entirety.
Trophos and AFM-Telethon today announce that data from the pivotal clinical trial of Trophos' lead product candidate olesoxime in spinal muscular atrophy (SMA) will be presented during the 66th American Academy of Neurology annual meeting to be held in Philadelphia, PA, USA, from April 26 to May 3 2014.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kirstin L Mikel, CRNA 9351 Lakebluff Dr, Clarkston, MI 48348-4184 Ph: (231) 590-4921 | Kirstin L Mikel, CRNA 1447 N Harrison St, Saginaw, MI 48602-4727 Ph: (231) 935-5770 |
News Archive
Europe's most promising oncology biotechs and other key stakeholders will gather in Oslo, Norway, September 15-17 for the 2nd European Cancer Cluster Meeting (ECCP 2010). Co-hosted by the Oslo Cancer Cluster and the Cancer-Bio-Santé Cluster from Toulouse, the two-day meeting is a unique partnering opportunity for oncology biotech companies, business development and licensing executives from the pharmaceutical industry and investors, as well as innovative researchers and clinicians.
People who have had their appendix removed may be at an increased risk for developing Parkinson's disease, according to new research.
Gilead Sciences, Inc. and MicroDose Therapeutx, Inc. today announced that the companies have entered into an exclusive worldwide license and collaboration agreement for the development and commercialization of MDT-637, MicroDose's inhalable small molecule antiviral fusion inhibitor for the treatment of respiratory syncytial virus (RSV).
Extendicare Real Estate Investment Trust ("Extendicare REIT") (TSX:EXE.UN) announced that a judge in Milwaukee County Circuit Court ruled that a class action lawsuit brought against Extendicare Health Services, Inc., Extendicare Homes, Inc. and other related entities (collectively "Extendicare"), wholly owned U.S. based subsidiaries of Extendicare REIT, was improper and ordered the case dismissed in its entirety.
Trophos and AFM-Telethon today announce that data from the pivotal clinical trial of Trophos' lead product candidate olesoxime in spinal muscular atrophy (SMA) will be presented during the 66th American Academy of Neurology annual meeting to be held in Philadelphia, PA, USA, from April 26 to May 3 2014.
› Verified 4 days ago
Theresa L Jones, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1447 N Harrison St, Saginaw, MI 48602 Phone: 989-583-0000 | |
William J Zwiers, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 700 Cooper Ave, Saginaw, MI 48602 Phone: 989-583-6200 | |
Mr. Michael Dennis Romanow, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1447 N Harrison St, Saginaw, MI 48602 Phone: 989-583-2794 | |
Christine Ann Smith, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1447 N Harrison St, Saginaw, MI 48602 Phone: 989-583-4673 Fax: 989-583-4635 | |
Lynn Ann Barnhart, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 700 Cooper Ave, Saginaw, MI 48602 Phone: 989-258-1003 | |
Mrs. Trari Bowdish, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 700 Cooper Ave, Saginaw, MI 48602 Phone: 989-583-0000 | |
Jesse L Mcdonald, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1447 N Harrison St, Saginaw, MI 48602 Phone: 989-583-4114 Fax: 989-583-1349 |